MannKind Appoints Ajay Ahuja As CMO
(RTTNews) - MannKind Corp. (MNKD), a biopharmaceutical company, on Monday announced that it has appointed Ajay Ahuja as Chief Medical Officer with immediate effect.
Ahuja will also take up the Executive Vice President role and will report directly to PharmD, Chief Executive Officer, Michael Castagna.
Ahuja brings more than 20 years of experience and has most recently served as Development and Launch Leader for a late-stage DNA-based therapeutic at Kardigan Bio. Ahuja also served in impactful roles at Pfizer, Novartis, and Tepha, Inc.
On Friday, MannKind closed trading 3.75% higher at $5.53 on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.